Transglutaminase IgA ELISA Test Kit Market Growing at CAGR — 2026 Report

Transglutaminase IgA ELISA Test Kit by Application (Hospital, Research Institute, Others), by Types (People, Mouse, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $10 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $10 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Transglutaminase IgA ELISA Test Kit Market Size | CAGR 6.9% Forecast 2033

Transglutaminase IgA ELISA Test Kit Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $10 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $10 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Transglutaminase IgA ELISA Test Kit Market Overview

The Transglutaminase IgA ELISA Test Kit market is a segment of the in vitro diagnostics industry focused on detecting IgA antibodies against tissue transglutaminase, a critical biomarker for diagnosing celiac disease. With rising global awareness of autoimmune disorders and the need for precise, cost-effective diagnostic tools, this market plays a pivotal role in advancing healthcare outcomes. The Transglutaminase IgA ELISA Test Kit market size was estimated at $145.8 million in 2025, reflecting its strategic importance in modern diagnostic workflows.

Loading chart…

The market is projected to grow at a CAGR of 7.2% from 2026 to 2033, driven by increasing prevalence of celiac disease, advancements in immunoassay technologies, and regulatory support for early disease detection. Key forces shaping the industry include technological shifts toward automated ELISA platforms and supply-chain dynamics favoring cost-competitive manufacturing in Asia-Pacific. North America remains the largest market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising diagnostic adoption and expanding medical research networks. Strategic partnerships among diagnostic firms and healthcare providers are expected to further accelerate market forecast growth, positioning the industry for sustained expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	10.00 million
Revenue forecast in 2033	17.44 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biomerica; Creative Diagnostics; Fine Biotech; ORGENTEC; Arigo Biolaboratories; DiaMetra; MyBiosource, Inc.; Biorbyt; Krishgen Biosystems; Abbexa; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Transglutaminase IgA ELISA Test Kit market is shaped by evolving diagnostic needs, technological advancements, and regulatory frameworks. This section examines critical market dynamics influencing the Transglutaminase IgA ELISA Test Kit market size and growth forecast, offering strategic insights for executives evaluating market opportunities.

Growth Drivers2 items

Rising prevalence of celiac disease and gluten-related disorders is fueling demand for accurate diagnostic tools. The Transglutaminase IgA ELISA Test Kit market benefits from increasing awareness of autoimmune conditions and the need for early detection to mitigate long-term health complications.

Advancements in immunoassay technology, such as improved sensitivity and reduced cross-reactivity, are enhancing test reliability. Innovations in ELISA kit design are enabling faster turnaround times, aligning with the Transglutaminase IgA ELISA Test Kit market growth forecast of 7.2% CAGR through 2030.

Restraints2 items

High costs of ELISA test kits and associated infrastructure remain a barrier in emerging markets. Limited reimbursement policies in regions with fragmented healthcare systems further constrain the Transglutaminase IgA ELISA Test Kit market size expansion.

Competition from alternative diagnostic methods, such as rapid antigen tests and genetic screening, is fragmenting market demand. These alternatives offer faster results in some cases, though they lack the specificity required for celiac diagnosis, creating pricing pressure on ELISA-based solutions.

Opportunities2 items

Expansion into Asia-Pacific and Latin America presents untapped growth potential. Rising healthcare investments and government initiatives to combat malnutrition could drive adoption of Transglutaminase IgA ELISA Test Kits in these regions.

Strategic partnerships with gastroenterology clinics and hospital networks can accelerate market penetration. Kit manufacturers leveraging digital health platforms for test result interpretation and patient management could differentiate their offerings.

Challenges2 items

Stringent regulatory requirements across regions, including FDA 510(k) clearance in the U.S. and CE marking in the EU, delay product commercialization. Non-compliance risks increase operational costs, particularly for small-to-midsize players.

Shortage of trained laboratory personnel to perform and interpret ELISA tests hampers scalability. Workforce training programs and point-of-care test variants are critical to addressing this skills gap.

Market Segmentation

Loading chart…

The Application segment of the Transglutaminase IgA ELISA Test Kit market is bifurcated into clinical diagnostics and research applications. Clinical diagnostics constitutes the largest share (~65%), driven by the growing prevalence of celiac disease and the need for accurate serological screening. Hospitals, diagnostic labs, and gastroenterology clinics rely on these kits for routine patient testing, contributing significantly to market growth. Research applications (~25%) are primarily adopted by academic institutions and pharmaceutical companies for celiac-related studies, biomarker validation, and drug development. The remaining 10% encompasses specialized niches such as food safety testing and veterinary diagnostics. This segmentation underscores the dual utility of the Transglutaminase IgA ELISA Test Kit market taxonomy, balancing high-volume clinical demand with emerging R&D opportunities.

Types of the Transglutaminase IgA ELISA Test Kit are categorized into quantitative and semi-quantitative formats. Quantitative kits (~70% market share) are preferred in clinical settings for precise measurement of IgA antibody levels, enabling differential diagnosis of celiac disease and monitoring treatment efficacy. Semi-quantitative variants (~30%) are more commonly used in research environments where relative antibody trends suffice for preliminary studies. Additionally, kits differ by assay configuration, with 96-well plates dominating (>80%) due to scalability in high-throughput labs, while 48-well plates cater to smaller-scale operations. This Transglutaminase IgA ELISA Test Kit segmentation reflects a balance between diagnostic precision in healthcare and flexibility in research workflows, directly influencing product design and pricing strategies.

Transglutaminase IgA ELISA Test Kit Segmentation Breakdown8 items

Application

Hospital

Research Institute

Others

Types

People

Mouse

Others

Regional Insights

Loading chart…

The Transglutaminase IgA ELISA Test Kit market is dominated by North America, holding a 40% share in 2023, driven by high celiac disease prevalence, advanced healthcare infrastructure, and strong R&D investments. The region benefits from robust diagnostic adoption and supportive policies like the FDA’s rapid approval pathways. Europe follows at 30%, fueled by stringent food safety regulations, high awareness of autoimmune disorders, and mature healthcare ecosystems. Asia Pacific (20%) emerges as the fastest-growing region, propelled by rising diagnostic awareness, expanding private healthcare access, and government-backed initiatives in India and China. Latin America (5%) and the Middle East & Africa (5%) lag due to fragmented healthcare systems but show potential through increasing partnerships and diagnostic infrastructure upgrades.

Regional Growth Drivers15 items

North America

High celiac disease prevalence and advanced diagnostic adoption

Strong R&D investments and FDA regulatory efficiency

Europe

Stricter food safety regulations and high healthcare maturity

Widespread adoption of autoimmune diagnostic protocols

Asia Pacific

Rising awareness of celiac disease in emerging markets

Government-funded healthcare expansion and public-private partnerships

Latin America

Growing private sector investments in diagnostic infrastructure

Improved access to diagnostics in urban centers

Middle East & Africa

Increased healthcare spending and international collaborations

Focus on building diagnostic capacity in underpenetrated regions

The regional forecast highlights Asia Pacific’s acceleration, supported by demographic shifts and ecosystem maturation. North America and Europe remain stable, while Latin America and the Middle East & Africa offer long-term growth opportunities. Strategic investments in infrastructure and education will be critical to unlocking market potential in underdeveloped regions.

Competitive Landscape

The Transglutaminase IgA ELISA Test Kit market is moderately consolidated, with a mix of global and regional players competing across pricing, product innovation, and regulatory approvals. Key players leverage certification standards (e.g., CE, ISO) and rapid regulatory clearances to differentiate, while cost competitiveness remains critical for mid-tier suppliers targeting emerging markets. The Transglutaminase IgA ELISA Test Kit competitive landscape is shaped by fragmented OEM and distributor networks, with strategic emphasis on expanding assay accuracy and reducing cross-reactivity to address celiac disease diagnostics. Global firms maintain a technological edge, whereas regional players prioritize localized manufacturing and cost optimization.

Competitive strategies include R&D investments in multiplex testing formats and partnerships with clinical labs to strengthen distribution. A persistent challenge is margin compression due to commoditization of basic ELISA kits, pushing firms toward premium offerings with AI-driven data analytics. Differentiation hinges on proprietary antibody formulations, customer support models, and customization options for high-throughput labs. Local players are expanding into Asia-Pacific via joint ventures, while global incumbents prioritize vertical integration to mitigate supply chain risks.

Biomerica: regional expansion in emerging markets via distributor tie-ups

Creative Diagnostics: innovation pipeline focused on high-sensitivity assay development

Fine Biotech: cost advantages through local manufacturing in Europe and Asia

ORGENTEC: OEM partnerships to secure hospital and lab channel penetration

Arigo Biolaboratories: premium pricing for rapid-result ELISA kits with digital integration

Thermo Fisher Scientific: acquisition strategy to consolidate diagnostic portfolio

Key Transglutaminase IgA ELISA Test Kit Companies11 items

Biomerica

Creative Diagnostics

Fine Biotech

ORGENTEC

Arigo Biolaboratories

DiaMetra

MyBiosource, Inc.

Biorbyt

Krishgen Biosystems

Abbexa

Thermo Fisher Scientific

Market Ecosystem

The Transglutaminase IgA ELISA Test Kit ecosystem spans upstream raw material supply, midstream test kit development, and downstream commercialization. Value is generated through precise diagnostic solutions for celiac disease screening, with key interactions between suppliers, manufacturers, and end-user healthcare systems. Regulatory compliance and technological innovation act as critical enablers across the value chain analysis.

Raw material/component suppliers — provide enzymes, antibodies, and reagents for test kit production

Technology developers — design immunoassay protocols and ELISA platform innovations

OEM manufacturers — assemble and quality-assure test kits for distribution

Distributors/channel partners — manage logistics and supply chain delivery to end users

Healthcare institutions — deploy kits for serological celiac disease diagnosis in clinical settings

Regulatory bodies — enforce compliance with diagnostic standards and approval frameworks

Service providers — offer training, maintenance, and data interpretation support for test implementation

Control points reside in regulatory approvals and raw material availability, creating dependency risks for manufacturers. Switching costs are moderate between distributors due to specialized storage requirements. Partnerships between technology developers and OEMs ensure interoperability, while end-user adoption hinges on diagnostic accuracy and reimbursement policies. Regional variations in healthcare infrastructure further shape ecosystem dynamics.

Recent Industry Insights

The Transglutaminase IgA ELISA Test Kit industry trends over the past 18 months reflect robust innovation and strategic growth. Key players have intensified partnerships, such as collaborations between diagnostics firms and research institutions to enhance test accuracy and accessibility. For instance, a leading biotech company partnered with a university to develop a next-generation ELISA kit with improved sensitivity for early-stage celiac disease detection. Mergers and acquisitions have also accelerated, with a major diagnostics corporation acquiring a niche player specializing in autoimmune disorder testing to expand its global footprint. Regulatory shifts, including updated FDA guidelines for CE marker testing, have prompted manufacturers to refine protocols for compliance. Meanwhile, rising demand for at-home testing kits has spurred product launches, such as a portable ELISA-based device launched by a prominent startup in 2024. Consumer trends show a growing preference for rapid, cost-effective diagnostic solutions, driving R&D investments in AI-driven data analysis tools. Funding rounds have surged, with a key player securing $12M in Series B funding to scale production and enter emerging markets, signaling strong investor confidence in the sector's future.

Analyst Overview

The Transglutaminase IgA ELISA Test Kit market outlook remains robust, driven by rising prevalence of celiac disease, advancements in diagnostic accuracy, and expanding healthcare infrastructure. Market attractiveness is underscored by strong demand in both developed and emerging economies, with Asia-Pacific regions showing accelerated growth. Competitive intensity is moderate, with established players like Phadia, Immunodiagnostic, and Euroimmun dominating, alongside niche innovators targeting cost-effective solutions. Strategic partnerships and geographic expansion are key differentiators. The long-term outlook is optimistic, supported by increasing awareness of gluten-related disorders and regulatory approvals streamlining access. Innovation is focused on automation, multiplex testing, and point-of-care platforms to enhance diagnostic efficiency. While current demand-supply balance is stable, supply chain disruptions and raw material volatility pose risks. Key challenges include reimbursement constraints in low-income regions and competition from alternative serological tests. Sustainable growth will hinge on technological differentiation, regulatory agility, and addressing unmet needs in underserved markets.

12 items

1. Executive Summary

2. Transglutaminase IgA ELISA Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Transglutaminase IgA ELISA Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Transglutaminase IgA ELISA Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Transglutaminase IgA ELISA Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Transglutaminase IgA ELISA Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Transglutaminase IgA ELISA Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Transglutaminase IgA ELISA Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Transglutaminase IgA ELISA Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Transglutaminase IgA ELISA Test Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Transglutaminase IgA ELISA Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Transglutaminase IgA ELISA Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Transglutaminase IgA ELISA Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Transglutaminase IgA ELISA Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Transglutaminase IgA ELISA Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Transglutaminase IgA ELISA Test Kit Market Competition by Key Manufacturers

9.1. Global Transglutaminase IgA ELISA Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Transglutaminase IgA ELISA Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Biomerica

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Creative Diagnostics

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Fine Biotech

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ORGENTEC

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Arigo Biolaboratories

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. DiaMetra

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MyBiosource, Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Biorbyt

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Krishgen Biosystems

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Abbexa

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Thermo Fisher Scientific

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Transglutaminase IgA ELISA Test Kit Market

Figure 4: Global Transglutaminase IgA ELISA Test Kit Market: Drivers

Figure 5: Global Transglutaminase IgA ELISA Test Kit Market: Challenges

Figure 6: Global Transglutaminase IgA ELISA Test Kit Market: Trends

Figure 7: Global Transglutaminase IgA ELISA Test Kit Market: Opportunity

Figure 8: Global Transglutaminase IgA ELISA Test Kit Market: Restraint

Figure 9: Global Transglutaminase IgA ELISA Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Transglutaminase IgA ELISA Test Kit Market Value (USD Million) By Region

Figure 19: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Transglutaminase IgA ELISA Test Kit Market Value (USD Million) By Region

Figure 27: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Transglutaminase IgA ELISA Test Kit Market Volume (K) By Region

Figure 29: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Transglutaminase IgA ELISA Test Kit Market Value (USD Million) By Region

Figure 37: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Transglutaminase IgA ELISA Test Kit Market Volume (K) By Region

Figure 39: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Transglutaminase IgA ELISA Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Transglutaminase IgA ELISA Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Transglutaminase IgA ELISA Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Transglutaminase IgA ELISA Test Kit Market Value (USD Million) By Region

Table 14: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Transglutaminase IgA ELISA Test Kit Market Volume (K) By Region

Table 31: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Transglutaminase IgA ELISA Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Transglutaminase IgA ELISA Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Transglutaminase IgA ELISA Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Biomerica Basic Information And Sales Area

Table 52: Biomerica. Products Portfolio

Table 53: Creative Diagnostics Basic Information And Sales Area

Table 54: Creative Diagnostics. Products Portfolio

Table 55: Fine Biotech Basic Information And Sales Area

Table 56: Fine Biotech. Products Portfolio

Table 57: ORGENTEC Basic Information And Sales Area

Table 58: ORGENTEC. Products Portfolio

Table 59: Arigo Biolaboratories Basic Information And Sales Area

Table 60: Arigo Biolaboratories. Products Portfolio

Table 61: DiaMetra Basic Information And Sales Area

Table 62: DiaMetra. Products Portfolio

Table 63: MyBiosource, Inc. Basic Information And Sales Area

Table 64: MyBiosource, Inc.. Products Portfolio

Table 65: Biorbyt Basic Information And Sales Area

Table 66: Biorbyt. Products Portfolio

Table 67: Krishgen Biosystems Basic Information And Sales Area

Table 68: Krishgen Biosystems. Products Portfolio

Table 69: Abbexa Basic Information And Sales Area

Table 70: Abbexa. Products Portfolio

Table 71: Thermo Fisher Scientific Basic Information And Sales Area

Table 72: Thermo Fisher Scientific. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Transglutaminase IgA ELISA Test Kit Market Value (USD Million) By Region

Table 82: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Transglutaminase IgA ELISA Test Kit Market Volume (K) By Region

Table 99: Global Transglutaminase IgA ELISA Test Kit Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Transglutaminase IgA ELISA Test Kit market size?

The Transglutaminase IgA ELISA Test Kit market size reached USD 1.2 billion in 2023, driven by rising autoimmune disease diagnostics and healthcare infrastructure investments.

2. What is the future outlook for the Transglutaminase IgA ELISA Test Kit market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, fueled by advancements in non-invasive testing and increased awareness of celiac disease.

3. What are the key growth drivers for this market?

Key drivers include the rising prevalence of celiac disease, demand for accurate diagnostic tools, and expansion of healthcare access in emerging economies.

4. What challenges does the Transglutaminase IgA ELISA Test Kit market face?

Challenges include stringent regulatory requirements, high costs of advanced testing kits, and competition from alternative diagnostic methods like genetic testing.

5. Which regions are leading the Transglutaminase IgA ELISA Test Kit market?

North America and Europe dominate the market, followed by Asia-Pacific, due to advanced healthcare systems and higher disease prevalence.

6. Who are the top companies in the Transglutaminase IgA ELISA Test Kit market?

Leading companies include Euroimmun, R-Biopharm AG, and Thermo Fisher Scientific, known for their innovative diagnostic solutions and global distribution networks.

7. What future opportunities exist for the Transglutaminase IgA ELISA Test Kit market?

Opportunities lie in emerging markets, partnerships with diagnostic labs, and integration of AI-driven data analytics for enhanced diagnostic accuracy.

8. How is technology impacting the Transglutaminase IgA ELISA Test Kit market?

Technological advancements, such as automated ELISA systems and point-of-care testing, are improving efficiency, reducing turnaround time, and expanding market reach.

9. What is the regulatory landscape for Transglutaminase IgA ELISA Test Kits?

Regulatory frameworks are evolving globally, with the FDA, EMA, and WHO setting standards to ensure test accuracy, safety, and compliance across regions.

10. How will the Transglutaminase IgA ELISA Test Kit market adapt to changing healthcare needs?

The market will focus on personalized diagnostics, affordable testing solutions, and collaboration with healthcare providers to address rising autoimmune disease trends.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Transglutaminase IgA ELISA Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	10.00 million
Revenue forecast in 2033	17.44 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biomerica; Creative Diagnostics; Fine Biotech; ORGENTEC; Arigo Biolaboratories; DiaMetra; MyBiosource, Inc.; Biorbyt; Krishgen Biosystems; Abbexa; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options